In prostate cancer, VEGF has been shown to induce EMT through an autocrine pathway 26, and the VEGF autocrine loop also stimulates the secretion of MMP2 and MMP9 in childhood acute lymphoblastic leukaemia 56. Here, MMP9 is linked to prostate cancer.